Industries/ Healthcare & Life Sciences/ Pharmaceutical Supply

Pharmaceutical Supply on PYRAX

Pharmaceutical supply chains span thousands of hops where a single counterfeit or diverted lot can be fatal, yet serialization data still lives in disconnected vendor databases. PYRAX anchors DSCSA/FMD-grade serialization and provenance on-chain, kills counterfeits with verifiable chain-of-custody, and keeps commercial terms shielded while still proving authenticity to any downstream party.

Market size
$4.9B pharma serialization & track-and-trace (2024)
Projection
$10.8B by 2030 · ~14.2% CAGR

The market

$200B+/yr
Est. global counterfeit-drug trade
~10.5%
Substandard/falsified meds in LMICs
>$10M
Avg. pharma recall cost
2024
DSCSA full interoperability deadline

Source: MarketsandMarkets, 2024. Figures are indicative and provided for context.

What's broken today

Counterfeit and diverted product enters the supply chain undetected, endangering patients and brands.
Serialization data is fragmented across CMOs, wholesalers, and dispensers with no shared verifiable ledger.
Recalls are slow and over-broad because affected lots cannot be pinpointed in real time.
Manufacturers must prove provenance to regulators without exposing pricing, volumes, or trade secrets.

How PYRAX transforms it

Concrete network elements mapped to this business.

Pharma serialization and provenance anchoring

Every unit and case serial is registered on-chain with an immutable custody trail, so a scan at the pharmacy cryptographically verifies the product is authentic and unrecalled.

Shielded-by-default commercial data

Provenance and authenticity are public-verifiable while prices, quantities, and counterparties stay encrypted as commitments — killing counterfeits without leaking trade terms.

IoT and device attestation

Cold-chain sensors sign temperature and location attestations on-chain, proving a biologic never broke its excursion limits from plant to patient.

eth_getProof for instant recall targeting

A recall query returns cryptographic proof of exactly which serials and custodians hold an affected lot, enabling surgical rather than blanket withdrawals.

Viewing keys for regulators

FDA or EMA inspectors receive a scoped read-only key to verify full chain-of-custody for an investigation without accessing the manufacturer's broader commercial ledger.

Buildathon: dApp ideas

Ship-ready concepts for pharmaceutical supply on PYRAX.

SerialGuard

01

Unit-level serialization registry; a pharmacy or patient scan returns a signed authenticity and recall-status proof.

serializationprovenanceanti-counterfeit

ColdProof

02

Cold-chain attestation feed where IoT loggers sign excursion-free proofs for biologics and vaccines.

IoTattestationprovenance

RecallRadar

03

Precision recall engine using eth_getProof to locate every custodian holding an affected lot in seconds.

eth_getProofrecallaudit

DivertWatch

04

Gray-market diversion detector that flags custody paths inconsistent with authorized distribution, without exposing pricing.

ZKprovenanceanalytics

TradeEscrow

05

Wholesaler settlement contract releasing payment only against verified delivery and authenticity proofs.

escrowEVMsettlement

InspectorKey

06

Regulator provenance portal reading full chain-of-custody through scoped viewing keys.

viewing-keyscomplianceaudit

APIOrigin

07

Active-ingredient origin tracker linking API lots to finished-goods serials for full backward traceability.

provenanceWASMserialization

VaccineTrace

08

Dose-level distribution ledger for public-health campaigns with instant finality on custody transfers.

finalityprovenanceIoT